Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells

被引:229
作者
Storch, A [1 ]
Paul, G
Csete, M
Boehm, BO
Carvey, PM
Kupsch, A
Schwarz, J
机构
[1] Univ Ulm, Sch Med, Dept Neurol, Ulm, Germany
[2] Univ Ulm, Sch Med, Dept Internal Med, Ulm, Germany
[3] Humboldt Univ, Charite, Dept Neurol, Berlin, Germany
[4] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA
[5] CALTECH, Div Biol, Pasadena, CA 92215 USA
[6] Rush Presbyterian St Lukes Med Ctr, Dept Pharmacol, Chicago, IL 60612 USA
[7] Rush Presbyterian St Lukes Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA
关键词
precursor cells; human; dopamine neurons; mesencephalon; cytokines; glial cell line-derived neurotrophic factor; differentiation; Parkinson's disease;
D O I
10.1006/exnr.2001.7706
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We report on generation of dopamine neurons from long-term cultures of human fetal mesencephalic precursor cells. These CNS precursor cells were successfully expanded in vitro using the mitogens epidermal growth factor (EGF) and fibroblast growth factor-2 (FGF-2). Incubation of these cultures in 3% atmospheric oxygen resulted in higher cellular yields than room air. Following incubation in differentiation media containing interleukin (IL)-1b (IL-1b), IL-11, leukemia inhibitory factor (LIF), and glial cell line-derived neurotrophic factor (GDNF), up to 1% of the precursor cells converted into cells immunoreactive for tyrosine hydroxylase (TH), a marker for dopamine neurons. The TH immunoreactive cells exhibited morphological and functional properties characteristic of dopamine neurons in culture. These precursor cells might serve as a useful source of human dopamine neurons for studying the development and degeneration of human dopamine neurons and may further serve as a continuous, on-demand source of cells for therapeutic transplantation in patients with Parkinson's disease. (C) 2001 Academic Press.
引用
收藏
页码:317 / 325
页数:9
相关论文
共 38 条
  • [11] Specification of dopaminergic and serotonergic neurons in the vertebrate CNS
    Hynes, M
    Rosenthal, A
    [J]. CURRENT OPINION IN NEUROBIOLOGY, 1999, 9 (01) : 26 - 36
  • [12] Kalyani AJ, 1998, J NEUROSCI, V18, P7856
  • [13] Dopaminergic transplants in patients with Parkinson's disease: Neuroanatomical correlates of clinical recovery
    Kordower, JH
    Goetz, CG
    Freeman, TB
    Olanow, CW
    [J]. EXPERIMENTAL NEUROLOGY, 1997, 144 (01) : 41 - 46
  • [14] Kukekov VG, 1997, GLIA, V21, P399, DOI 10.1002/(SICI)1098-1136(199712)21:4<399::AID-GLIA7>3.0.CO
  • [15] 2-Z
  • [16] Multipotent stem/progenitor cells with similar properties arise from two neurogenic regions of adult human brain
    Kukekov, VG
    Laywell, ED
    Suslov, O
    Davies, K
    Scheffler, B
    Thomas, LB
    O'Brien, TF
    Kusakabe, M
    Steindler, DA
    [J]. EXPERIMENTAL NEUROLOGY, 1999, 156 (02) : 333 - 344
  • [17] GRAFTS OF FETAL DOPAMINE NEURONS SURVIVE AND IMPROVE MOTOR FUNCTION IN PARKINSONS-DISEASE
    LINDVALL, O
    BRUNDIN, P
    WIDNER, H
    REHNCRONA, S
    GUSTAVII, B
    FRACKOWIAK, R
    LEENDERS, KL
    SAWLE, G
    ROTHWELL, JC
    MARSDEN, CD
    BJORKLUND, A
    [J]. SCIENCE, 1990, 247 (4942) : 574 - 577
  • [18] Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines
    Ling, ZD
    Potter, ED
    Lipton, JW
    Carvey, PM
    [J]. EXPERIMENTAL NEUROLOGY, 1998, 149 (02) : 411 - 423
  • [19] Isolation of lineage-restricted neuronal precursors from multipotent neuroepithelial stem cells
    MayerProschel, M
    Kalyani, AJ
    Mujtaba, T
    Rao, MS
    [J]. NEURON, 1997, 19 (04) : 773 - 785
  • [20] Stem cells in the central nervous system
    McKay, R
    [J]. SCIENCE, 1997, 276 (5309) : 66 - 71